Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Prepaid Assets: 2022-2024

Historic Prepaid Assets for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to $11.1 million.

  • Stoke Therapeutics' Prepaid Assets fell 21.25% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year decrease of 21.25%. This contributed to the annual value of $11.1 million for FY2024, which is 1.79% down from last year.
  • According to the latest figures from FY2024, Stoke Therapeutics' Prepaid Assets is $11.1 million, which was down 1.79% from $11.3 million recorded in FY2023.
  • Stoke Therapeutics' 5-year Prepaid Assets high stood at $11.3 million for FY2023, and its period low was $10.9 million during FY2022.
  • Moreover, its 3-year median value for Prepaid Assets was $11.1 million (2024), whereas its average is $11.1 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first rose by 3.55% in 2023, then fell by 1.79% in 2024.
  • Over the past 3 years, Stoke Therapeutics' Prepaid Assets (Yearly) stood at $10.9 million in 2022, then increased by 3.55% to $11.3 million in 2023, then decreased by 1.79% to $11.1 million in 2024.